1-(1-Ethyl-1H-pyrazole-4-sulfonyl)-piperidine-3-carboxylic acid
|
- $378 - $796.95
- Product name: 1-(1-Ethyl-1H-pyrazole-4-sulfonyl)-piperidine-3-carboxylic acid
- CAS: 957477-71-3
- MF: C11H17N3O4S
- MW: 287.34
- EINECS:
- MDL Number:MFCD07400410
- Synonyms:1-(1-Ethyl-1H-pyrazole-4-sulfonyl)-piperidine-3-carboxylic acid;1-(1-ethylpyrazol-4-yl)sulfonylpiperidine-3-carboxylic acid;3-Piperidinecarboxylic acid, 1-[(1-ethyl-1H-pyrazol-4-yl)sulfonyl]-
3 prices
Selected condition：
Brand
- American Custom Chemicals Corporation
- Crysdot
- Matrix Scientific
Package
- 500MG
- 1g
- 5g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0082188
- Product description1-(1-ETHYL-1H-PYRAZOLE-4-SULFONYL)-PIPERIDINE-3-CARBOXYLIC ACID 95.00%
- Packaging500MG
- Price$796.95
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11003214
- Product description1-((1-Ethyl-1H-pyrazol-4-yl)sulfonyl)piperidine-3-carboxylicacid 97%
- Packaging5g
- Price$701
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number033960
- Product description1-(1-Ethyl-1H-pyrazole-4-sulfonyl)-piperidine-3-carboxylic acid
- Packaging1g
- Price$378
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| American Custom Chemicals Corporation | CHM0082188 | 1-(1-ETHYL-1H-PYRAZOLE-4-SULFONYL)-PIPERIDINE-3-CARBOXYLIC ACID 95.00% | 500MG | $796.95 | 2021-12-16 | Buy |
| Crysdot | CD11003214 | 1-((1-Ethyl-1H-pyrazol-4-yl)sulfonyl)piperidine-3-carboxylicacid 97% | 5g | $701 | 2021-12-16 | Buy |
| Matrix Scientific | 033960 | 1-(1-Ethyl-1H-pyrazole-4-sulfonyl)-piperidine-3-carboxylic acid | 1g | $378 | 2021-12-16 | Buy |
Properties
Boiling point :512.0±60.0 °C(Predicted)
Density :1.48±0.1 g/cm3(Predicted)
pka :4.22±0.20(Predicted)
Density :1.48±0.1 g/cm3(Predicted)
pka :4.22±0.20(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|